Hepatitis E occurs sporadically and as outbreaks due to contamination of drinking 2 1 water. The causative agent, hepatitis E virus (HEV) is a hepatotropic non-enveloped 2 2 RNA virus, which grows poorly in vitro. Consequently, many aspects of HEV biology 2 3 are poorly characterized, including its cellular receptor and entry mechanism(s).
Transfections. Plasmid transfections were done with jetPRIME (Polypus 1 3 9
Transfection) according to manufacturer's instructions. For siRNA transfections, 0.25 1 4 0 x10 6 cells (Huh-7 or HEK293) were seeded in each well of a 6-well plate and grown 1 4 1 without antibiotics. After reaching 70% confluence, cells were transfected with 50 nM 1 4 2 siRNA against ATP5B or with a non-specific scrambled siRNA as control, incubated 1 4 3 for 4 hours in a serum-free medium followed by complete medium without antibiotics were then used for either western blotting or flow cytomtery. Cloning of the HEV-LP was done as described previously (Holla et al., 2015) . Briefly, with some modifications. Briefly, cells were grown in 100 mm dishes up to 80% 1 7 8 confluence, washed and treated with Sulfo-NHS-SS-Biotin in PBS for 30 min on ice. After washing, the cells were treated with Quenching Solution, pelleted and lysed in 1 8 0 9 PBS containing the protease inhibitor cocktail by sonication at 25 amp pulse for 5 sec 1 8 1 (and a 10 sec off interval) for a total of 3 min on ice. The lysate was incubated with 1 8 2 NeutraAvidin agarose beads for 2 hr at 4°C with end-to-end mixing. The beads were 1 8 3 washed with PBS and bound biotinylated proteins were eluted in PBS containing 50 1 8 4 mM DTT, which was subsequently removed by dialysis against PBS. In the second 1 8 5 approach, membrane fractions were isolated by ultracentrifugation. Cells in 100 mm 1 8 6 dishes were washed with PBS, scraped and lysed in PBS containing protease 1 8 7 inhibitor cocktail as above. The cell debris and nuclei were removed by centrifugation 1 8 8
at 600 x g for 10 min at 4°C, and the membrane fraction was pelleted down in a 1 8 9
SW41Ti rotor (Beckman) at 29,000 rpm for 1 hr at 4°C. This membrane pellet was 1 9 0 washed once with PBS containing protease inhibitor cocktail by ultracentrifugation as 1 9 1 above and resuspended in 400 μ l PBS. This was layered over a sucrose step 1 9 2 gradient made up of 900 μ l each of 45%, 35%, 20% and 5% sucrose (w/v) up to a 1 9 3 total volume of 4 ml. The gradient was centrifuged at 42,000 rpm in a SW55-Ti rotor 1 9 4 for 16 hr at 4°C. From this, nine fractions of 330 μ l were collected from the top (F1-1 9 5 F9) and 40 μ l of each fraction was resolved on a SDS-12% polyacrylamide gel, 1 9 6 transferred to nitrocellulose membrane and western blotting was done for ATP5B, 1 9 7
Calenexin, Cytochrome c and EGFR. interacting membrane proteins, the fractions from Huh-7 and HEK293 cell lines were 2 0 0 pre-cleared with Ni-NTA beads for 2 hr before incubating with purified HEV-LP 2 0 1 overnight at 4°C on a rotator. The mixture was then added to Ni-NTA beads and 2 0 2 incubated at room temperature for 1 hr. The beads were washed and proteins were 2 0 3 eluted by boiling in 1x SDS loading dye at 95°C for 10 min. Proteins were separated 2 0 4 by SDS-PAGE and stained with Coomassie Blue. The bands were excised, cut into 2 0 5 1 0 small pieces and in-gel tryptic digestion was carried out as described (Shevchenko et   2  0  6 al., 2006). Briefly, gel pieces were destained in 100 μ l of destaining solution (25 mM 2 0 7 NH 4 HCO 3 and 50% CH 3 CN) by rinsing 3-4 times, centrifuging at 1000 rpm for 1 min 2 0 8 and discarding the supernatant till the gel pieces were completely destained. These were then dried in a vacuum concentrator. Trypsin solution (13 ng/μl, in 25 mM 2 1 0 NH 4 HCO 3 ) was added to the dried gel pieces and incubated at 37°C overnight, 2 1 1 following which the sample was centrifuged at 1000 rpm for 1 min and digested iodoacetamide in UA buffer) were added to the filter for 20 min, followed by four 2 2 2 washes with UA buffer. The filter was then equilibrated for tryptic digestion by 14,000 x g. This step was repeated twice before adding trypsin diluted in ABC buffer 2 2 5 (trypsin to protein ratio 1:100) for 8 hr at 37°C. The digested peptides were eluted in 2 2 6 a new collection tube, acidified with trifluoroacetic acid (TFA) and subjected to mass experiments, cells were grown on coverslips in 12-well plates. To stain intracellular 2 3 0 1 1 molecules, cells were fixed with 2% paraformaldehyde in PBS for 15 min and then 2 3 1 permeabilized with 0.04% Triton X100. Blocking was done with 5% BSA for 30 min at 2 3 2 room temperature followed by staining with appropriate primary antibodies and 2 3 3 fluorophore-conjugated secondary antibodies in 1% BSA for 1 hr. After each antibody internalized FITC-VLP and ATP5B, the FITC-VLPs were bound to cells on ice for 1 2 3 7 hr, washed with ice-cold PBS to remove unbound material and then shifted to 37°C 2 3 8 to allow internalization for different times. Internalization was terminated by adding 2 3 9 ice-cold PBS to cells. Surface bound VLPs were removed by first treating cells with 2 4 0 trypsin-EDTA for 30 sec and then with surface stripping buffer (0.2% glacial acetic 2 4 1 acid, 500 mM NaCl) for 1 min. The cells were fixed, permeabilized and stained with 2 4 2 ATP5B primary antibody and Alexa Fluor 568 conjugated secondary antibody. All 2 4 3 images were acquired on a Nikon A1R confocal laser scanning microscope (cLSM).
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Images were processed using Image J (http://rsbweb.nih.gov/ij/download.html) and 2 4 5 colocalization coefficients were calculated using the NIS-Elements Microscope 2 4 6 Imaging Software. Plasmid DNA isolation. All plasmids were prepared using the RBC HiYield Plasmid antibody; the anti-ATP5B stained cells were further stained with an appropriate 2 5 7 secondary antibody. Cells were washed and subjected to flow cytometric analysis. Appropriate isotype control antibodies were used as primary antibodies for all 2 5 9 stainings. For antibody and HEV-LP binding and blocking experiments, cells were incubated 2 6 1 with anti-ATP5B (or isotype control) antibodies for 2 hr on ice or with HEV-LPs for 1 2 6 2 hr on ice. After incubation, the cells were fixed, washed with FACS buffer and 2 6 3 incubated with HEV-LPs for 1 hr or with ATP5B antibodies for 2 hr, respectively. Cells were then washed and stained with anti-HEV capsid antibody and a fluorophore 2 6 5 conjugated secondary antibody and subjected to flow cytometry. Western blotting. Isolated membrane proteins were run on 10 or 12% denaturing 2 7 2 polyacrylamide gels containing SDS, transferred to nitrocellulose membranes 2 7 3 (Advanced Microdevices, India), blocked with 5% w/v BSA for 2 hr at room Streptavidin-HRP at a dilution of 1:5000. of the purified protein were run on a reducing SDS-polyacrylamide gel, which 3 1 2 migrated between the 26 and 34 kDa markers (Fig. 1a) . The purified protein also protein eluted in the void volume of a TSK3000 silica gel column (separation range 3 1 8 10-500 kDa), indicating that higher order structures were being formed, and DLS 3 1 9 measurements showed the average diameter of the particles to be 34 nm. We then 3 2 0 checked the ability of these HEV-LPs to bind to cells of hepatic (Huh-7) and non-3 2 1 hepatic (HEK293) origin by flow cytometry, and found the binding to be higher on the 3 2 2 former compared to the latter (Fig. 1c) . These cell lines are considered permissive and non-permissive for HEV, respectively. Additionally, compared to HEK293 cells, carcinoma) (Fig. S1 ). The C-terminal 6X Histidine tag present on the p239 monomer was used to 3 2 8 immobilize the HEV-LPs to Ni-NTA beads. Membrane fractions from HEK293 and 3 2 9
Huh-7 cells were passed over the immobilized HEV-LPs, the interacting proteins 3 3 0 were eluted and resolved by SDS-PAGE. Two bands corresponding to 56.5 kDa and 3 3 1 68.5 kDa were observed for both the cell lines (Fig. 1d) . The bands were excised, 3 3 2 subjected to in-gel tryptic digestion, and the proteins were identified by mass 3 3 3 spectrometry to be ATP synthase subunit β (ATP5B) and Ribophorin I (RPN I) ( Table   3 3 4 S1). assay, we isolated the total cell surface proteins from Huh-7 and HEK293 cells, and 3 3 8 subjected these fractions to in-sol tryptic digestion and MALDI-TOF spectrometry. ATP5B was identified from Huh-7 cells, and not from HEK 293 cells (Table S2 ). Additionally, the alpha subunit (ATP5A) was also identified from Huh-7 cells, indicating that the two subunits may be forming a larger complex on the cell surface We also studied the localization and expression levels of ATP5B by flow cytometry with ATP5B antibodies and subjected to flow cytometry. The ATP5B levels were 3 4 5 higher on Huh-7 cells as compared to HEK293 cells ( Fig. 1e; p<0 .01), and this was 3 4 6 consistent with HEV-LP binding to these cells (Fig. 1c ). We also subjected 3 4 7 membrane fractions from Huh-7 and HEK293 cells to western blotting for ATP5B. A HEK293 cells, but the levels were significantly higher in the former as compared to 3 5 0 the latter (Fig. 1f ). Total cell lysates from Huh-7 and HEK293 cells showed high 3 5 1 levels of ATP5B in both cell types. To ensure that membrane fractions were devoid of 3 5 2 1 6 cytoplasmic contaminants, they were probed for Actin and EGFR was used as a 3 5 3 loading control. Plasma membrane fractionation protocols are subject to 3 5 4 contamination from internal membranes. To ensure that ATP5B was not a 3 5 5 contaminant from internal membranes, we carried out sucrose density gradient and Cytochrome C (mitochondria) (Fig. S2) . The ATP5B protein was found Calnexin and Cytochrome C in these fractions from both Huh-7 and HEK293 cells. Blocking of ATP5B reduces HEV-LP binding and virus infection. We then 3 6 3 checked whether antibody-mediated masking of cell surface exposed ATP5B of cells with anti-ATP5B antibodies reduced the binding of HEV-LPs compared to 3 6 8 cells treated with an isotype control antibody ( Fig. 2a, 2b; p<0 .005). Conversely, 3 6 9
when Huh-7 cells were first incubated with HEV-LPs, fixed and subsequently stained 3 7 0 with anti-ATP5B antibodies, the detectable surface levels of ATP5B were significantly 3 7 1 reduced ( Fig. 2c, d; p<0 .05). To further validate these findings, we infected antibody 3 7 2 pre-treated Huh-7 cells with HEV and estimated the virus in these cells two days viral titers were found to be reduced by 1.5-2 log 10 levels in cells pre-treated with 3 7 5 ATP5B antibodies compared to the isotype control antibody (Fig. 2e, p<0 .01). The binding of HEV-LP was also checked on cells transfected with siRNA against 3 7 7 ATP5B. Knockdown of total cellular levels of ATP5B were checked in siRNA 3 7 8 transfected cells by western blotting. There was about 5-fold and 1.5-fold reduction in 3 7 9 ATP5B levels in Huh-7 and HEK293 cells, respectively (Fig. 3a ). This was also 3 8 0 reflected in the levels of ectopic ATP5B on surface staining of siRNA transfected 3 8 1 cells with anti-ATP5B antibodies. In Huh-7 cells there was a significant reduction in 3 8 2 ectopic ATP5B levels (Fig. 3b; p<0 .01), and even though HEK293 cells also showed 3 8 3 reduced ectopic ATP5B levels, the difference was not significant (Fig. 3c) . As received ATP5B siRNA compared to scrambled siRNA transfected cells (Fig. 3d, 3e) . The extent of inhibition was greater for Huh-7 cells compared to HEK293 cells. As in 3 8 7 the case of antibody-mediated block, we wanted to test siRNA transfected cells for an essential protein such as ATP synthase, made these cells non-viable. to surface receptors and are internalized along with the receptor in the form of a 3 9 4 complex. We therefore asked whether cell surface bound HEV-LPs colocalized with 3 9 5 ectopic ATP5B. For this, the HEV-LPs were labelled with FITC as described in Materials and Methods; these particles are called FITC-VLPs. Saturating anti-ATP5B antibody. The colocalization of surface bound FITC-VLPs was observed 4 0 0 with cell surface ATP5B ( Fig. 4a; n=22 , Pearson's coefficient=0.597). Alternatively, remained associated with ATP5B at 30 and 60 min, but the association was lost by 2 4 0 7 hours post-internalization ( Fig. 4b, 4c, 4d ). Binding of virus or HEV-LP to receptor and is used as a marker for these membrane microdomains. To check if the HEV-LP 4 1 8 was associated with lipid rafts during entry, we carried out binding of FITC-VLP and 4 1 9 biotinylated CTxB to cells on ice for 1 hr, washed the cells and isolated lipid rafts The surface bound FITC-VLP was found to partition to GM1-positive (raft enriched) the raft fractions (Fig. 5a ). When FITC-VLP was allowed to internalize at 37°C for 1 4 2 5 hr after binding on ice, it remained associated with the GM1-positive fractions, 4 2 6 1 9 although a significant portion was redistributed to the EGFR-positive non-raft regions 4 2 7 (Fig. 5b ). Since the VLP co-trafficks with ATP5B up to 1 hour post internalization 4 2 8 (Figure 4 ), we conclude that some part of the internalized VLP remains associated 4 2 9 with internalized ATP5B in the raft regions. binding to one or more specific receptors. We have previously shown that HSPGs, were identified using a HEV-LP mediated pull down of plasma membrane proteins. The results were counter-intuitive since both of these molecules are not classically 4 5 0 present on the cell surface. The ATP5B is part of the mitochondrial F 1 -F 0 ATPase but 4 5 1 is also found on the plasma membrane (Chi & Pizzo, 2006) ; RPN1 is part of the 4 5 2 oligosachcharyltransferase complex in the rough endoplasmic reticulum (RER) and is has not been reported to be present on the cell surface, our flow cytometric analyses 4 5 5 and western blotting of plasma membrane fractions do indicate this (data not shown).
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The ATP5B contains the catalytic core of the large multi-subunit ATP synthase 4 5 7 complex, which drives ATP synthesis in the mitochondria (Boyer, 1997).
5 8
Mitochondrial ATP synthase is translocated to cholesterol-rich 'lipid raft' regions of 2 2 internalization, following which this association was lost. The internalized HEV-LPs 4 9 9 also colocalized with CTxB, which binds the GM1 receptor and is a marker for 5 0 0 cholesterol-enriched membrane microdomains or 'lipid rafts ' (Torgersen et al., 2001) .
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This was also the case when these membrane microdomains were prepared using 5 0 2 cold Triton extraction and sucrose gradient centrifugation. This could be due to 5 0 3 binding of the HEV-LPs to the ectopic ATP synthase complex, which resides in these 5 0 4 membrane fractions (Kim et al., 2004) . To validate our findings, surface exposed 5 0 5 ATP5B was blocked with specific antibodies and the cells were infected with virions replication is likely to be due compromised HEV binding and internalization, and 5 0 9 validates our findings that ATP5B is involved in the binding and entry of HEV into 5 1 0 liver cells. 
